Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) VaccineFirst published 25/06/2021 Last updated 24/01/2025 EU PAS number: EUPAS41623StudyOngoing